US BANCORP \DE\ - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 34 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$28,352
-57.0%
32,000
-23.6%
0.00%
Q3 2022$66,000
-10.8%
41,880
+13.1%
0.00%
Q2 2022$74,000
-23.7%
37,034
-11.4%
0.00%
Q1 2022$97,000
-34.9%
41,810
+31.2%
0.00%
Q4 2021$149,000
-23.6%
31,869
+24.5%
0.00%
Q3 2021$195,000
-22.3%
25,600
-0.9%
0.00%
Q2 2021$251,000
+28.7%
25,840
+10.0%
0.00%
Q1 2021$195,000
+62.5%
23,490
+33.3%
0.00%
Q4 2020$120,000
-36.8%
17,627
+3.4%
0.00%
Q3 2020$190,000
+156.8%
17,046
+46.3%
0.00%
Q2 2020$74,00011,6540.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
B. Riley Financial, Inc. 5,216,250$4,621,5981.04%
B. Riley Securities, Inc. 5,216,250$4,621,5981.00%
EMFO, LLC 209,398$185,5270.19%
Wellspring Financial Advisors, LLC 483,551$428,4260.14%
Mayo Clinic 300,000$267,0000.14%
swisspartners Ltd. 110,000$97,4650.12%
Donald L. Hagan, LLC 169,514$150,1890.09%
Oaktree Fund Advisors, LLC 66,000$58,4760.09%
EUDAIMONIA ADVISORS LLC 138,887$123,0540.08%
Asset Management Resources, LLC 138,020$122,2860.08%
View complete list of SORRENTO THERAPEUTICS INC shareholders